Gene Sequencing, The Driver Of Personalized Medicine – Seeking Alpha


Seeking Alpha

Gene Sequencing, The Driver Of Personalized Medicine
Seeking Alpha
In 2016, 46% of Illumina's revenue came from outside the U.S. The company is best known for their genome sequencing products, including their top of the line HiSeq X Ten instrument. The HiSeq X Ten is capable of sequencing over 18,000 human genomes …

Source: Genome Sequencing